期刊文献+

术前肺动脉高压对肺纤维化患者肺移植术后早期存活率的影响 被引量:8

Effect of preoperative pulmonary artery pressure on early survival after lung transplantation for idiopathic pulmonary fibrosis
原文传递
导出
摘要 目的探讨术前肺动脉高压对特发性肺纤维化(IPE)患者肺移植术后早期(〈90d)存活率的影响。方法2002年9月至2009年4月为30例特发性肺纤维化患者进行了肺移植。根据术前肺动脉压的检测结果,将30例患者分为两组。肺动脉高压组:13例,术前平均肺动脉压≥30mmHg;对照组:17冽,术前平均肺动脉压〈30mmHg。对两组患者的年龄、术式(单、双肺移植)、肺动脉压力、是否应用体外膜氧合(ECMO)等进行多因素逻辑回归分析比较。结果肺动脉高压组和对照组患者肺移植术后早期存活率分别为61.5%和94.1%,两组比较,差异有统计学意义(P〈0.05)。统计学分析显示.术前肺动脉高压是影响患者肺移植术后早期存活率的独立危险因素,而年龄、术式及是否使用ECMO等并非是影响肺移植术后早期存活率的独立危险因素。结论术前肺动脉高压是影响患者肺移植术后早期存活率的独立危险因素;特发性肺纤维化患者肺移植前应重点评估其肺动脉压力; Objective To estimate the effects of preoperative pulmonary hypertension on early survival (91) days) after lung transplantation for idiopathic pulmonary fibrosis (IPF). Methods We reviewed 30 cases of lung transplant patients which suffered from IPF. According to the pulmonary artery pressure,non-pulmonary hypertension group (n = 17) and pulmonary hypertension group (n = 13) were set up. Risk factors were assessed individually and adjusted for confounding by a multivariabte logistic regression model. The early outcomes (90 days) were compared in two groups by the Х^2 test. Results The early survival rate was 61.5% and 94. 1 % in pulmonary hypertension group and non-pulmonary hypertension group respectively (P〈0.05). Multivariate analysis confirmed that mean pulmonary artery pressure was independent risk factors after adjustment for potential confounders. Recipient age, operating procedure, and use of extracorporeal membrane oxygenation (ECMO) were not independent risk factors for early mortality. Conclusion The increased pulmonary artery pressure is an independent risk factor for death after single-lung transplantation in IPF. Mean pulmonary artery pressure should be included in the overall risk assessment of patients with IPF evaluated for lung transplantation.
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2009年第12期737-739,共3页 Chinese Journal of Organ Transplantation
基金 2008年国家科技支撑计划(2008BAI160B05)
关键词 高血压 肺性 肺纤维化 肺移植 存活率 Hypertension, pulmonary Pulmonary fibrosis Lung transplantation Survival rate
  • 相关文献

参考文献12

  • 1陈静瑜,胡春晓,朱乾坤,张建余,郑明峰,何毅军,陈若.改良低钾右旋糖酐液供肺灌注保存的临床观察[J].中华医学杂志,2004,84(17):1416-1417. 被引量:75
  • 2陈静瑜,郑明峰,何毅军,朱乾坤,胡春晓,陈若,朱大伟,苏正兴,叶书高.单肺移植治疗终末期肺病肺气肿[J].中华外科杂志,2003,41(6):404-406. 被引量:44
  • 3朱艳红,陈静瑜.肺移植围术期监测与并发症的治疗[J].山东医药,2005,45(27):77-78. 被引量:9
  • 4朱艳红,陈静瑜,郑明峰,胡春晓,何毅军,王永功.肺移植围术期的并发症处理(附18例报告)[J].中国危重病急救医学,2006,18(7):394-396. 被引量:14
  • 5Christie JD, Edwards LB, Aurora P, et al. Registry of the International Society for Heart and Lung Transplantation: twenty - fifth official adult lung and heart/lung transplantation report - - 2008. J Heart Lung Transplant, 2008,27 (9) : 957- 969.
  • 6Short AF, Wainright JL, Cors CS, et al. Pulmonary hypertension in patients with pulmonary fibrosis awaiting tung transplant. Eur Respir J ,2007,30(4) : 715-721.
  • 7Nathan SD,Shlobin OA,Ahmad S,et al. Serial development of pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Respiration, 2008,76 (3):288-294.
  • 8Bando K, Keenan RJ, Paradis IL, et al. Impact of pulmonary hypertension on outcome after single-lung transplantation. Ann Thorac Surg, 1994,58(5) : 1336-1342.
  • 9Huerd SS, Hodges TN,Grover FL, et al. Secondary pulmonary hypertension does not adversely affect outcome after single lung transplantation. J Thorac Cardiovasc Surg, 2000, 119 (3):458- 465.
  • 10Cassivi SD, Meyers BF, Battafarano RJ, et al. Thirteen-year experience in lung transplantation for emphysema. Ann Thorac Surg,202,74(5) : 1663 -1669.

二级参考文献27

  • 1陈静瑜,胡春晓,朱乾坤,张建余,郑明峰,何毅军,陈若.改良低钾右旋糖酐液供肺灌注保存的临床观察[J].中华医学杂志,2004,84(17):1416-1417. 被引量:75
  • 2卢大乔,张红金,陈德昌.肾移植术后重症肺部真菌感染的诊治分析[J].中国危重病急救医学,2005,17(6):377-378. 被引量:12
  • 3陈玉平,张志泰,韩玲,胡燕生,宋飞强,区颂雷,李昕,周福有.肺移植治疗肺纤维化一例报告[J].中华外科杂志,1996,34(1):25-28. 被引量:36
  • 4Toronto Lung Transplant Group.Unilateral lung transplantation for pulmonary fibrosis.N Engl Med,1986,314:1140.
  • 5Hosenpud JD,Bennnett LE,Keck BM,et al.The registry of the International Society for Heart and Lung Transplantation:eighteenth official report-2001.J Heart Lung Transplant,2001,20:805-816.
  • 6Keshavjee SH,Yamazaki F,Yokomise H,et al. The role of dextran 40 and potassium in extended hypothermic lung preservation for transplantation.J Thorac Cardiovasc Surg,1992,103:314-325.
  • 7Fischer S,Matte-Martyn A,Perrot MD,et al.Low-patassium dextran preservation solution improves lung function after human lung transplantation.J Thorac Cardiovasc Surg,2001,121:594-596.
  • 8Fischer S,Hopkinson D,Mingyao Liu,et al. Raffinose improves the function of rat pulmonary grafts stored for twenty-four hours in low-potassium dextran solution. J Thorac Cardiovasc Surg,2000,119: 488-492.
  • 9Bitu-Moreno J,Francischetti I,Siemer R,et al.Influence of different routes of flush perfusion on the distribution of lung preservation solutions in parenchyma and airways.Eur J Cardiothorac Surg,1999,15:481-489.
  • 10Fischer S,Hopkinson D,Mingyao Liu,et al.Raffinose improves 24-hour lung preservation in low potassium dextran glucose solution:a histologic and ultrastructural analysis.Ann Thorac Surg ,2001,71:1140-1145.

共引文献106

同被引文献102

引证文献8

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部